The Chemours Company (FRA:2CU)
Germany flag Germany · Delayed Price · Currency is EUR
15.53
-2.27 (-12.76%)
At close: Feb 20, 2026

The Chemours Company Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-38686-238578608
Depreciation & Amortization
340301307291317
Other Amortization
1112999
Loss (Gain) From Sale of Assets
-8-3-110-21-115
Asset Writedown & Restructuring Costs
-56---
Loss (Gain) on Equity Investments
-7-111-22-11
Stock-Based Compensation
2115182734
Other Operating Activities
115-47-61-4-49
Change in Accounts Receivable
106-152-1091-225
Change in Inventory
-106-14658-294-210
Change in Accounts Payable
-165-9-72105281
Change in Other Net Operating Assets
343-745644-5175
Operating Cash Flow
264-633556755814
Operating Cash Flow Growth
---26.36%-7.25%0.87%
Capital Expenditures
-213-360-370-307-277
Sale of Property, Plant & Equipment
735--
Divestitures
--13816508
Sale (Purchase) of Real Estate
---17-
Other Investing Activities
-4-2-10-11
Investing Cash Flow
-206-353-229-284220
Long-Term Debt Issued
828699771105741
Total Debt Issued
828699771105741
Long-Term Debt Repaid
-889-604-378-185-949
Total Debt Repaid
-889-604-378-185-949
Net Debt Issued (Repaid)
-6195393-80-208
Issuance of Common Stock
-9195123
Repurchase of Common Stock
-1-3-88-501-175
Common Dividends Paid
-78-148-149-154-164
Other Financing Activities
1411-3-2-30
Financing Cash Flow
-126-36172-686-554
Foreign Exchange Rate Adjustments
29-224-32-34
Net Cash Flow
-39-1,044503-247446
Free Cash Flow
51-993186448537
Free Cash Flow Growth
---58.48%-16.57%-0.56%
Free Cash Flow Margin
0.88%-17.17%3.06%6.56%8.46%
Free Cash Flow Per Share
0.34-6.611.252.833.18
Cash Interest Paid
251267223164180
Cash Income Tax Paid
747354131149
Levered Free Cash Flow
-76-287315220.75443.25
Unlevered Free Cash Flow
81.13-134436313.63549.88
Change in Working Capital
178-1,052620-10321
Source: S&P Global Market Intelligence. Standard template. Financial Sources.